GPX4 and hepatocellular carcinoma: The results showed that in-016975/Sora@PLGA-CM boosted the sensitivity of orthotopic HCC to sorafenib and effectively suppress tumor progression by inducing hsa_piR_016975/Maspin/GPX4 axis-mediated ferroptosis.